Library / Laws / 116th Congress / House Bills / H.R. 2917
H.R. 2917
To hold pharmaceutical companies accountable for dubious marketing and distribution of opioid products and for their role in creating and exacerbating the opioid epidemic in the United States.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in House | 2019-05-22 | 15.5K | ⠃⠗⠋ |